Dissolved and financials
CVR: 37815578
DKK -6,000
Gross profit
Net result: DKK -5,271
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 29 July 2019
CVR · view overview
No headcount reported
Director role ended: Michael Olav Justad
CVR · 29/07/2019
View the full event history
Nuclear Pharma Danmark ApS was a Danish company of the type Anpartsselskab based in Odder, founded in 2016. The company has been dissolved on 29 July 2019. The company was registered under the industry Specialiseret engroshandel med fødevarer i.a.n.. In 2018, the company reported a gross profit of DKK -6,000 and a net result of DKK -5,271 compared with DKK -21,200 the year before. Equity in the 2018 report amounted to DKK 25,075.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 201801/07/2017 – 30/06/2018 | -6 t. | -5 t. | 34 t. | 25 t. | - | |
| 201714/06/2016 – 30/06/2017 | -21 t. | -21 t. | 52 t. | 30 t. | - |
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationNo. Nuclear Pharma Danmark ApS is registered in the Danish CVR register with the status Dissolved and ceased on 29 July 2019.
The CVR number of Nuclear Pharma Danmark ApS is 37815578.
In 2018, Nuclear Pharma Danmark ApS reported a gross profit of DKK -6,000.
Nuclear Pharma Danmark ApS was founded on 14 June 2016.
Nuclear Pharma Danmark ApS was registered under the industry Specialiseret engroshandel med fødevarer i.a.n. (industry code 463890).
Nuclear Pharma Danmark ApS was located at c/o Michael Olav Justad, Langholts Ager 2, 8300 Odder.
As of July 29, 2019, Michael Olav Justad has stepped down as director of Nuclear Pharma Danmark ApS.
Nuclear Pharma Danmark ApS was dissolved on July 29, 2019.
Nuclear Pharma Danmark ApS has published its annual report for 2018. Gross profit came to DKK -6,000, and the net result was DKK -5,271.
Nuclear Pharma Danmark ApS has published its annual report for 2017. Gross profit came to DKK -20,948, and the net result was DKK -21,200.
As of June 14, 2016, Michael Olav Justad is registered as director of Nuclear Pharma Danmark ApS.
Nuclear Pharma Danmark ApS was founded on June 14, 2016.
Companies in the same industry and area
